Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Aminopeptidase N Driven Signaling in the Development of Pulmonary Hypertension

Award Number: K99HL171869
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP
PERIOD OF PERFORMANCE START DATE: 05/01/2024
PERIOD OF PERFORMANCE END DATE: 07/31/2025

Group Awards By:

View Award Description

Aminopeptidase N Driven Signaling in the Development of Pulmonary Hypertension - PROJECT SUMMARY/ABSTRACT CANDIDATE: Dr. James's career objective is to establish an independent research group investigating mitochondrial dysfunction (MD) and Aminopeptidase N (APN) driven signaling in pulmonary hypertension (PH). The overall research and career development plan is carefully crafted to impart the necessary skills for Dr. James to establish a novel and independent line of research. The plan includes the following objectives: 1) gain additional training in research methodology and professional development; 2) developing strong publication records; 3) presenting his work at scientific meetings to make an impact on the field 4) obtaining preliminary data for his first independent grant. ENVIRONMENT: The primary mentor Dr. Rafikov is an expert in mitochondrial dysfunction and PH. He will provide guidance and technical expertise for aspects in all aims. Co-Mentor Dr. Vinicio de Jesus Perez is an expert in pericyte biology and PH and will train Dr. James in pericyte isolation, co- culture, and data analysis. Co-mentor Dr. Ralph Fregosi is an expert electrophysiologist and will extensively prepare Dr. James in his career development in addition to training with patch clamp techniques. All the mentors with the rest of the advisory committee will ensure the success of Dr. James's proposal. All the proposed work will be carried out in Dr. Rafikov's laboratory with training gained from labs of Dr. de Jesus Perez and Dr. Zhiyu Dai for single cell transcriptomics. Dr. Rafikov has all the necessary funding from NIH and other sources to support Dr. James during the K99 training phase. The Department of Medicine at the University of Arizona has excellent facilities and supportive faculty members and provides a nurturing environment for the training phase. RESEARCH: The overarching hypothesis is that MD triggers the overexpression of the protein, APN in pericytes. APN has been shown to cause migration, invasion, and proliferation of cells. Preliminary data suggests that MD in rats triggers an increase in pericyte APN, causing them to dissociate from endothelial cells (EC's) in capillaries, transform into smooth muscle-like cells (PASMC) and proliferate. This ultimately leads to vascular remodeling and PH. Three specific aims will address this hypothesis. Aim 1: To Investigate the role of APN in pericyte-EC communication and pericyte transformation to PASMC. Aim 2: To Investigate the role of MD on APN expression and signaling. Aim 3: To Verify the impact of blocking APN and reversing MD on vascular remodeling in PH. The study will utilize several techniques including single cell transcriptomics, 3D imaging and co-culture to address these questions. The results of this study will lead to a better understanding of how MD drives APN expression and signaling. This could define novel targets in the treatment of PH for favorable clinical outcomes. The proposed training will enable Dr. James to acquire new experimental skills and execute his research plan successfully. This will allow Dr. James to become self-sufficient, able to secure extramural funding and a tenure- track position at a top-tier research institution.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $0 )
2026	2025	TRUSTEES OF INDIANA UNIVERSITY	980 INDIANA AVE RM 2232	INDIANAPOLIS	IN	46202	MARION	USA	Lung Diseases Research	000	2	1/18/2026	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2025 ( Subtotal = $102,403 )
2025	2025	TRUSTEES OF INDIANA UNIVERSITY	980 INDIANA AVE RM 2232	INDIANAPOLIS	IN	46202	MARION	USA	Lung Diseases Research	000	2	4/8/2025	NON-COMPETING CONTINUATION	$102,403
2025	2025	TRUSTEES OF INDIANA UNIVERSITY	980 INDIANA AVE RM 2232	INDIANAPOLIS	IN	46202	MARION	USA	Lung Diseases Research	001	2	7/25/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $102,403

Issue Date FY: 2024 ( Subtotal = $102,403 )
2024	2024	TRUSTEES OF INDIANA UNIVERSITY	980 INDIANA AVE RM 2232	INDIANAPOLIS	IN	46202	MARION	USA	Lung Diseases Research	000	1	4/30/2024	NEW	$102,403
														Subtotal = $102,403

Grand Total All Awards = $204,806

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Aminopeptidase N Driven Signaling in the Development of Pulmonary Hypertension

Award Number: K99HL171869

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP

PERIOD OF PERFORMANCE START DATE: 05/01/2024

PERIOD OF PERFORMANCE END DATE: 07/31/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer